Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients

NCT04046263 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT04046263
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04046263 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients
Lead sponsor
University of Colorado, Denver
Phase
Phase 4
Overall status
Completed
Start date
February 1, 2020
Completion date
July 31, 2021
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperphosphatemia, hypoalbuminemia, peritoneal dialysis complication